Stay updated with breaking news from Negma Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
On Tuesday morning, European stock markets are headed for a slightly down opening, just below the parity line, as investors choose caution in anticipation of macroeconomic data to be released later in...
European stock markets open subdued on Tuesday as investors remain cautious ahead of the on inflation expected later this week, which will help to understand whether the Fed and ECB have really...
Piazza Affari closed just below par on Monday's session, on a day that was not particularly crisp from a macroeconomic standpoint and also poor in news from listed companies. Chris Beauchamp, chief...
By Ben Glickman Evaxion Biotech said Friday that it needs additional funding to keep the business running into 2024. The Danish clinical-stage biotechnology...
Financing, available in multiple tranches over the next three years, could extend the Company’s runway into Q4 2024Transaction will enable Evaxion to advance its next-generation cancer vaccine, EVX-03, towards a Phase 1 clinical trial Copenhagen, DENMARK, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage biotechnology company specializing in the development of AI-powered immunotherapies, today announced that it has entered into a